Ocumetics Technology Corp (TSE:OTC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ocumetics Technology Corp. has identified potential improvements in its accommodative intraocular lens design during internal tests, which could enhance performance and safety. The company will re-manufacture the lenses, causing a 45 to 60-day delay in its first human trials, but believes these enhancements will set new industry benchmarks.
For further insights into TSE:OTC stock, check out TipRanks’ Stock Analysis page.